Pharmacoepidemiological study of migraine with the focus on 5HT1-receptor agonists
- At: 2012 FIP Congress in Amsterdam (the Netherlands)
- Type: Poster
- By: TRUTER, Ilse (Nelson Mandela Metropolitan University, Drug Utilization Research Unit (DURU), Port Elizabeth, South Africa)
The WHO estimates the prevalence of migraine to be 3%-7% in Africa. Little information is available on the burden of illness of migraine in Africa.
To determine the prescribing trends of antimigraine drugs utilising a large community pharmacy prescription database.
A retrospective, cross-sectional pharmacoepidemiological The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.